Search
for

    Glossary Decreased Libido

    reduced interest in sexual activity

    Decreased libido, also known as low libido or reduced sex drive, refers to a diminished interest in sexual activity. This condition can be influenced by various factors, including hormonal imbalances, psychological issues such as stress or depression, certain medications, and underlying medical conditions. Understanding the root cause is essential for effective treatment, which may involve lifestyle changes, therapy, or medical interventions.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. A Phase II Study of Vaginal Testosterone Cream (TEST) vs. Estring for Vaginal Dryness or Decreased Libido in Women with Early Stage Breast Cancer (BC) Treated with Aromatase Inhibitors (AIs). Cancer Research · 2009 · 9 citations
    2. Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia Archives of Dermatology · 2010 · 152 citations
    3. Finasteride Drugs · 1999 · 125 citations
    4. A Prospective, 1-Year Trial Using Saw Palmetto Versus Finasteride in the Treatment of Category III Prostatitis/Chronic Pelvic Pain Syndrome The Journal of Urology · 2004 · 105 citations
    5. Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride American Journal of Men's Health · 2014 · 81 citations
    6. 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection The Journal of Sexual Medicine · 2008 · 78 citations
    7. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials The Journal of Sexual Medicine · 2016 · 57 citations
    8. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia Journal of Dermatology · 2011 · 41 citations
    9. Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman Annals of internal medicine · 1978 · 39 citations
    10. Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review Sexual medicine reviews · 2013 · 35 citations
    11. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. PubMed · 2016 · 32 citations
    12. Finasteride Treatment of Hair Loss in Women Annals of Pharmacotherapy · 2010 · 29 citations
    13. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review Dermatology Online Journal · 2017 · 21 citations
    14. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    15. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia Annals of Dermatology · 2016 · 19 citations
    16. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis Acta dermato-venereologica · 2018 · 15 citations
    17. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men’s Health Current Urology Reports · 2018 · 13 citations
    18. Sexual dysfunction in men taking systemic dermatologic medication: A systematic review Journal of The American Academy of Dermatology · 2019 · 11 citations
    19. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors Sexual medicine reviews · 2018 · 10 citations
    20. ‘Post-finasteride syndrome’: what to tell our female patients? British Journal of Dermatology · 2018 · 4 citations
    21. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    22. Topical Minoxidil 5% Induced Male Sexual Dysfunction Zenodo (CERN European Organization for Nuclear Research) · 2017 · 2 citations
    23. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Actas Dermo-Sifiliográficas · 2016 · 1 citations
    24. Getting to grips with hair loss Inpharma Weekly · 1997 · 1 citations
    25. DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS Asclepius International Journal of Scientific Health Science · 2026
    26. Unexpected Hair Regrowth Following Oral Bicalutamide Exposure in a Male Patient With Androgenetic Alopecia and a Suboptimal Response to Conventional Therapies: A Case Report Cureus · 2026
    27. Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review Frontiers in Medicine · 2026
    28. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026
    29. Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia 2026
    30. Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review Journal of Pre-Clinical and Clinical Research · 2025